Long-Term Survival of Patients With Chemotherapy-Naïve Metastatic Nasopharyngeal Carcinoma Receiving Cetuximab Plus Docetaxel and Cisplatin Regimen

Purpose: Metastatic nasopharyngeal carcinoma (mNPC) remains incurable. This prospective study aimed to investigate whether adding cetuximab to cisplatin-based induction therapy could improve efficacy and survival for chemotherapy-naïve mNPC patients. Patients and Methods: Eligible chemotherapy-naïve...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Front Oncol
Main Authors: Zhang, Mengping, Huang, He, Li, Xueying, Huang, Ying, Chen, Chunyan, Fang, Xiaojie, Wang, Zhao, Guo, Chengcheng, Lam, Sioteng, Fu, Xiaohong, Hong, Huangming, Tian, Ying, Lu, Taixiang, Lin, Tongyu
Format: Artigo
Jezik:Inglês
Izdano: Frontiers Media S.A. 2020
Teme:
Oncology
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7319102/
https://ncbi.nlm.nih.gov/pubmed/32637360
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2020.01011
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki